MBL-HCV1

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMBL-HCV1
Drug Alias NameMBL-HCV1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAnti-E2
TargetsHepatitis C virus E2 glycoprotein
Therapy Area/IndicationsHepatitis CRejection of liver transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMassbiologics
China Registration ClassN/A

Develop Information

Active CompaniesMassbiologics
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsRejection of liver transplantation

Other Information

ATC CodeN/A
Related LinksN/A